Black Diamond Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Black Diamond Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Black Diamond Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Black Diamond Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $1.4k | 279 | 5.07 |
| 2023-12-31 | $769 | 274 | 2.81 |
| 2023-09-30 | $1.0k | 360 | 2.87 |
| 2023-06-30 | $1.2k | 247 | 5.05 |
| 2022-12-31 | $429 | 239 | 1.80 |
| 2022-09-30 | $0 | 735 | 0.00 |
| 2022-06-30 | $1.3k | 751 | 1.67 |
| 2022-03-31 | $5.8k | 1.9k | 3.01 |
| 2021-12-31 | $53k | 10k | 5.34 |
| 2021-09-30 | $0 | 14k | 0.00 |
| 2021-06-30 | $178k | 13k | 13.33 |
| 2021-03-31 | $16M | 670k | 24.26 |
| 2020-12-31 | $21M | 664k | 32.05 |
| 2020-09-30 | $14M | 462k | 30.23 |
| 2020-06-30 | $12M | 285k | 42.16 |
| 2020-03-31 | $453k | 18k | 24.92 |